A question for the more Pharma literate among us.
What are we hoping to find in the upcoming/imminent Cobra results and other ongoing trials?
The company is endeavouring to build a first in class portfolio which will lead to a big dollar sale prior to product commercialisation so I’m hoping someone with experience in the area could explain what the best case and negatives that we should be watching out for.
All results so far have shown no negatives for toxicity in increasing dosage and clear as day images coming through. What more do we hope to see?
A question for the more Pharma literate among us.What are we...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.78 |
Change
-0.040(1.05%) |
Mkt cap ! $1.178B | |||
| Open | High | Low | Value | Volume |
| $3.85 | $3.89 | $3.74 | $1.709M | 449.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 125 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.78 | 5200 | 2 |
View Market Depth
| Last trade - 11.10am 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.72 |
Change
-0.040 ( 2.33 %) |
||||
| Open | High | Low | Volume | ||
| $3.85 | $3.85 | $3.70 | 45970 | ||
| Last updated 11.30am 07/05/2024 ? | |||||
| CU6 (ASX) Chart |